SARCOMA, EWING
Clinical trials for SARCOMA, EWING explained in plain language.
Never miss a new study
Get alerted when new SARCOMA, EWING trials appear
Sign up with your email to follow new studies for SARCOMA, EWING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for tough childhood cancer: new combo targets relapsed Ewing's sarcoma
Disease control OngoingThis study tests whether adding the drug abemaciclib to standard chemotherapy can help children and young adults with Ewing's sarcoma that has returned or not responded to treatment. About 46 participants will receive either the new combination or chemotherapy alone. The goal is …
Matched conditions: SARCOMA, EWING
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New hope for young cancer patients: experimental combo targets tough tumors
Disease control TerminatedThis study tests a new drug called PEN-866 combined with two standard chemotherapy drugs (vincristine and temozolomide) for adolescents and young adults aged 12-39 whose solid tumors, including Ewing sarcoma and rhabdomyosarcoma, have come back or not responded to standard treatm…
Matched conditions: SARCOMA, EWING
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC